Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Cash from Operations of 26743000.0 for Q1 2026, down 461.0% year-over-year from 7408000.0 in Q1 2025, and down 120.52% quarter-over-quarter from 130315000.0 in Q4 2025.
Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Cash from Operations history runs 10 years deep, the most recent figure standing at 26743000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 461.0% year-over-year to 26743000.0; the TTM figure through Mar 2026 stood at 305841000.0 (changed 0.35% YoY), while the FY2025 annual figure was 339992000.0, up 15.21% from the prior year.
- Cash from Operations for Q1 2026 stood at 26743000.0, down from 130315000.0 in the prior quarter.
- The five-year high for Cash from Operations was 141774000.0 in Q3 2024, with the low at 125521000.0 in Q2 2022.
- The 5-year median for Cash from Operations is 83819000.0 (2025), against an average of 59942647.06.
- The sharpest annual moves came in 2023 and 2026: Cash from Operations soared 683.13% in 2023, then plunged 461.0% in 2026.
- Amneal Pharmaceuticals' Cash from Operations stood at 23292000.0 in 2022, then jumped by 683.13% to 135823000.0 in 2023, then slipped by 13.06% to 118078000.0 in 2024, then grew by 10.36% to 130315000.0 in 2025, then sank by 120.52% to 26743000.0 in 2026.
- Business Quant data shows AMRX's Cash from Operations at 26743000.0 in Q1 2026, 130315000.0 in Q4 2025, and 118450000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.39 Bn | 43.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.74 Bn | 5.61 Bn | 334.51 Mn | -21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.24 Mn |
| Jun 30, 2026 | -21.24 Mn |
| Mar 31, 2026 | -26.74 Mn |
| Mar 31, 2026 | -26.74 Mn |
| Dec 31, 2025 | 130.32 Mn |
| Dec 31, 2025 | 130.32 Mn |
| Sep 30, 2025 | 118.45 Mn |
| Sep 30, 2025 | 118.45 Mn |
| Jun 30, 2025 | 83.82 Mn |
| Jun 30, 2025 | 83.82 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Dec 31, 2024 | 118.08 Mn |
| Dec 31, 2024 | 118.08 Mn |
| Sep 30, 2024 | 141.77 Mn |
| Sep 30, 2024 | 141.77 Mn |
| Jun 30, 2024 | 39.66 Mn |
| Jun 30, 2024 | 39.66 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.41 Mn |